129 related articles for article (PubMed ID: 9853989)
21. Lack of concordance between EMIT assay and LC-MS/MS for Therapeutic Drug Monitoring of Mycophenolic Acid: Potential increased risk for graft rejection?
De Nicolò A; Ianniello A; Benagli C; Della Bruna R; Keller F; Antonucci M; D'Avolio A; Cantù M
J Pharm Biomed Anal; 2020 Aug; 187():113337. PubMed ID: 32442868
[TBL] [Abstract][Full Text] [Related]
22. Mycophenolic acid monitoring: evaluation of the EMIT MPA immunoassay in kidney and lung transplantation.
Brunet M; Oppenheimer F; Martorell J; Vilardell J; Carreño MC; Carrillo M; Corbella J
Transplant Proc; 1999 Sep; 31(6):2275-6. PubMed ID: 10500574
[No Abstract] [Full Text] [Related]
23. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
[TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacokinetics of mycophenolate mofetil.
Bullingham RE; Nicholls AJ; Kamm BR
Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
[TBL] [Abstract][Full Text] [Related]
25. Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients.
Cai W; Cai Q; Xiong N; Qin Y; Lai L; Sun X; Hu Y
Transplant Proc; 2018 Jun; 50(5):1298-1304. PubMed ID: 29735215
[TBL] [Abstract][Full Text] [Related]
26. Comparison of mycophenolic acid concentrations determined by a new PETINIA assay on the dimension EXL analyzer and a HPLC-UV method.
Dasgupta A; Tso G; Chow L
Clin Biochem; 2013 May; 46(7-8):685-7. PubMed ID: 23219740
[TBL] [Abstract][Full Text] [Related]
27. CEDIA mycophenolic acid assay compared with HPLC-UV in specimens from transplant recipients.
Westley IS; Ray JE; Morris RG
Ther Drug Monit; 2006 Oct; 28(5):632-6. PubMed ID: 17038877
[TBL] [Abstract][Full Text] [Related]
28. Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients.
Mandla R; Line PD; Midtvedt K; Bergan S
Ther Drug Monit; 2003 Jun; 25(3):407-14. PubMed ID: 12766573
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of mycophenolic acid during the early period after renal transplant.
Nazemian F; Mohammadpur AH; Abtahi B; Naghibi M
Exp Clin Transplant; 2007 Dec; 5(2):658-63. PubMed ID: 18194117
[TBL] [Abstract][Full Text] [Related]
30. Influence of renal graft function on mycophenolic acid pharmacokinetics during the early period after kidney transplant.
Mohammadpur AH; Nazemian F; Abtahi B; Naghibi M
Exp Clin Transplant; 2008 Dec; 6(4):276-81. PubMed ID: 19338489
[TBL] [Abstract][Full Text] [Related]
31. Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients.
McBride JH; Kim SS; Rodgerson DO; Reyes AF; Ota MK
Clin Chem; 1992 Nov; 38(11):2300-6. PubMed ID: 1424128
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.
Atcheson BA; Taylor PJ; Mudge DW; Johnson DW; Hawley CM; Campbell SB; Isbel NM; Pillans PI; Tett SE
Br J Clin Pharmacol; 2005 Mar; 59(3):271-80. PubMed ID: 15752372
[TBL] [Abstract][Full Text] [Related]
33. Positive bias in mycophenolic acid concentrations determined by the CEDIA assay compared to HPLC-UV method: is CEDIA assay suitable for therapeutic drug monitoring of mycophenolic acid?
Dasgupta A; Johnson M
J Clin Lab Anal; 2013 Jan; 27(1):77-80. PubMed ID: 23325745
[TBL] [Abstract][Full Text] [Related]
34. An isocratic high performance liquid chromatographic method for quantification of mycophenolic acid and its glucuronide metabolite in human serum using liquid-liquid extraction: application to human pharmacokinetic studies.
Bahrami G; Mohammadi B
Clin Chim Acta; 2006 Aug; 370(1-2):185-90. PubMed ID: 16707117
[TBL] [Abstract][Full Text] [Related]
35. Development of an Abbreviated Mycophenolic Acid Area Under the Time-Concentration Curve for Renal Transplant Patients Under Enteric-Coated Mycophenolate Sodium: A Comparison With Critical Analysis of Available Equations.
David-Neto E; Triboni AH; Ramos F; Agena F; Romano P
Ther Drug Monit; 2018 Aug; 40(4):411-416. PubMed ID: 29746396
[TBL] [Abstract][Full Text] [Related]
36. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
37. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous determination of mycophenolate and its metabolite mycophenolate-7-o-glucuronide with an isocratic HPLC-UV-based method in human plasma and stability evaluation.
Rissling O; Bauer S; Shipkova M; Glander P; Mai M; Hambach P; Budde K
Scand J Clin Lab Invest; 2016 Dec; 76(8):612-619. PubMed ID: 27676419
[TBL] [Abstract][Full Text] [Related]
39. Rapid and simple determination of mycophenolic acid in human plasma by ion-pair RP-LC with fluorescence detection.
Hosotsubo H; Takahara S; Kokado Y; Permpongkosol S; Wang JD; Tanaka T; Matsumiya K; Kitamura M; Okuyama A; Sugimoto H
J Pharm Biomed Anal; 2001 Feb; 24(4):555-60. PubMed ID: 11272311
[TBL] [Abstract][Full Text] [Related]
40. Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry.
Annesley TM; Clayton LT
Clin Chem; 2005 May; 51(5):872-7. PubMed ID: 15746301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
